T1	Participants 103 134	in HIV-HCV-coinfected patients:
T2	Participants 310 340	in HIV-HCV-coinfected patients
T3	Participants 342 399	METHODS HIV and HCV genotype 1- and 4-coinfected subjects
T4	Participants 891 936	RESULTS A total of 67 patients were included;
